SAM
REGN icon

Sagewood Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Sagewood Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$556K Sell
892
-136
-13% -$92.6K 0.13% 164
2026
Q1 		$794K Buy
1,028
+123
+14% +$94.2K 0.25% 73
2025
Q4 		$699K Buy
+905
New +$615K 0.25% 72

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sagewood Asset Management's REGN Position: Q2 2026 in Review

Sagewood Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 13% in Q2 2026, selling an estimated $92.6K and leaving 892 shares worth $556K. The position accounts for 0.13% of the portfolio, ranked #164.

Sagewood Asset Management first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $794K in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Sagewood Asset Management held 892 shares of Regeneron Pharmaceuticals worth $556K as of Q2 2026.
  • Sagewood Asset Management sold 136 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $92.6K.
  • Regeneron Pharmaceuticals made up 0.13% of Sagewood Asset Management's portfolio in Q2 2026, its #164 holding.
  • Sagewood Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Sagewood Asset Management's Regeneron Pharmaceuticals position peaked at $794K in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.